- About Us
- For Business
- For Entrepreneurs
- For Faculty, Staff, Clinicians
- Contact Us
UK attends 2007 BIO International Convention
LEXINGTON, Ky. (May 2, 2007) – University of Kentucky faculty and several university-related biotech start-up companies will attend the 2007 BIO International Convention at the Boston Convention & Exhibition Center, May 6-9.
The annual biotechnology showcase draws about 20,000 attendees and serves to educate the public and policymakers about biotechnology, while fostering partnering meetings and other business development activities that keep the industry growing.
University of Kentucky President Lee T. Todd Jr. will once again lead the UK delegation including:
- Len Heller, Vice President for Commercialization & Economic Development
- Chuck Staben, Associate Vice President for Research
- William Balke, Associate Provost for Clinical and Translational Science
- Eric Grulke, Associate Dean for Research & Graduate Studies, College of Engineering
- Joe Wyse, President & CEO, Coldstream Laboratories Inc.
- Dean Harvey, Director, Von Allmen Center for Entrepreneurship
- Geanie Umberger, Assistant Director for Clinical Research
- Orlando Chambers, Biotechnology Relations Director, Kentucky Tobacco Research & Development Center
- Deb Weis, Marketing & Communications, Research, Commercialization & Economic Development
Four UK-affiliated biotech start-up companies will also attend BIO:
AllTranz, a specialty pharmaceutical company specializing in transdermal delivery methods of drugsand R&D associated with skin-related toxicity testing and transdermal/topical product development.
Audra Stinchcomb, CSO and founder
Associate Professor, Pharmaceutical Sciences
ALT BioScience is a specialty bioscience company that discovers, develops, and commercializes diagnostic and biomedical technologies with a focus on oral-systemic health and neurodegenerative diseases.
Leslie Herzog, President & CEO; Marsha Melville, Sales & Operations Manager
Nano-Mite Technologies Inc., based on the research of Patrick G. Sullivan, with UK’s Spinal Cord & Brain Injury Research Center (SCoBIRC), is focused on controlling obesity—in both humans and pets—using nanotechnology, and is currently testing a nano-scale medical device that serves as mitochondrial uncouplers to increase metabolism and result in weight loss.
Greg Johnson, CEO
Mimetic Solutions LLC is a biopharmaceutical company specializing in smart release polymers that are highly specific for triggered release of drugs, chemicals, or other bioactive agents.
Zach Hilt, Chief Scientist
Assistant Professor, Chemical Engineering
BIO 2007 is sponsored by the Biotechnology Industry Organization (BIO), founded in 1993, is a nonprofit association that represents more than 1,100 biotechnology companies, state and international affiliates, and related organizations. BIO members develop and market revolutionary products in health, food and agriculture, and industrial and environmental biotechnology. Most of our member firms are small, capital-intensive companies whose ideas are still in research and development.
Dr. Todd will host a UK Alumni Reception while in Boston.